Table 3.
Adverse events experienced by at least two patients
| Patients who experienced any of the following | Alectinib 900 mg BID (n = 8) |
|---|---|
| Constipation | 5 (62.5) |
| Dyspnoea | 4 (50.0) |
| Fatigue | 3 (37.5) |
| Headache | 3 (37.5) |
| Diarrhoea | 2 (25.0) |
| Blood bilirubin increased | 2 (25.0) |
| Blood creatine phosphokinase increased | 2 (25.0) |
| Hypokalaemia | 2 (25.0) |
| Pruritus | 2 (25.0) |
| Myalgia | 2 (25.0) |
| Anaemia | 2 (25.0) |
| Insomnia | 2 (25.0) |
AE – adverse event, BID – twice daily
Data are presented as n (%).